The rise of patients collecting their own samples for diagnostic tests seems poised to change how we approach health care in ...

Pap smears are especially traumatic when providers fail to respond compassionately to patients’ pain. Bonnie Gross, who has ...

A new study published in the Journal of Infectious Diseases by researcher Helen Trottier, epidemiologist at the Azrieli ...

Krantz says that companies generally take some time to fall to this point. He gives the example of retailer Aeropostale, which had stated it was looking for strategic alternatives in 2015.

For example, if your small business made widgets out of gadgets, you'd need to find vendors with all the gadgets you need. You might find one vendor that has them all or would need to find ...

Half of Quebec’s administrative regions now offer the Human Papillomavirus (HPV) test, which will replace the Pap test throughout the province by the end of the year. Montérégie is the most recent ...

Almost 650 girls in Ireland reported requiring medical intervention or treatment after receiving the HPV vaccine, according to data collected by the State’s medicines watchdog. The Health ...

Human Papillomavirus (HPV) is one of the most common sexually transmitted infections globally. The World Health Organization (WHO) estimates that over 80 per cent of sexually active individuals ...

Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide and there is a strong link between certain high-risk viral types and cervical carcinogenesis. Although ...

“He’s a fine young man. I think his example is a true example of development. He matured and developed for two years, and now he’s getting an opportunity, and his experiences will help him ...

HPV causes about 70% of oropharyngeal cancers ... it could drastically change how we treat patients; for example, being able to use less treatment leading to fewer side effects," said Faden.

A self-collection (SC) device that could easily be used at home proved safe and accurate for cervical screening in the SELF-CERV prospective nonrandomized clinical trial, as reported in JAMA ...